Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck's Capital Idea: Industry's Latest Push to Strengthen VC Ties

Sep 01 2011

Related Content

CMEA Ventures Into Development, But Not Tied To Lilly As Expected

Jun 27 2011

At Merck, Business Development As Usual?

Mar 01 2010

Corporate VC Adds a Business Development Flavor

Nov 01 2007

Boehringer Ingelheim Joins The Corporate Venture Party

Apr 01 2010

Lilly's Evolving Corporate Venture Model

Oct 01 2010

In the Midst Of A Shakeout, Biotech VCs Must Embrace New Partners, New Math

Sep 01 2010

Sanofi Reworks R&D To Tackle Risk, Meet Unmet Need

May 01 2011

Atlas, CMEA Test New Biotech Model

Apr 01 2011

The A-List: 2010's Trend-Shaping Series A Financings

Jan 01 2011

Health Care Information Technology: Venture's New Darling?

Jun 01 2011

BioPontis Aims To Bridge "Valley Of Death"

Feb 01 2011

Related Companies

Merck & Co., Inc.

Eli Lilly and Company

AstraZeneca PLC

Sanofi

Novartis AG

Johnson & Johnson

Pfizer Inc.

Johnson & Johnson

Amgen, Inc.

GSK plc

Baxter International Inc.

Boehringer Ingelheim GmbH

Takeda Pharmaceutical Co. Ltd.

Abbott

Merck KGaA

Merck & Co., Inc.

KAHR Medical Ltd.

More from In Vivo Archive

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window